Document is current
Any future updates will be listed below
-
Authors
Brunner, Thomas B. https://orcid.org/0000-0002-6780-2820
Boda-Heggemann, Judit
Bürgy, Daniel
Corradini, Stefanie
Dieckmann, Ute Karin
Gawish, Ahmed
Gerum, Sabine
Gkika, Eleni
Grohmann, Maximilian
Hörner-Rieber, Juliane
Kirste, Simon
Klement, Rainer J.
Moustakis, Christos
Nestle, Ursula
Niyazi, Maximilian
Rühle, Alexander
Lang, Stephanie-Tanadini
Winkler, Peter
Zurl, Brigitte
Wittig-Sauerwein, Andrea
Blanck, Oliver
-
Funding
Funding for this research was provided by:
Medical University of Graz
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 2 June 2024
First Online: 12 July 2024
Conflict of interest
: TB: AstraZeneca (speaker), Onconovum (speaker), Heckel (research support), Brainlab (research support), Varian (educational); JBH: EBAMed SA (Consultant), Elekta (Research), AstraZeneca (Education / Meeting Faculty); DB: Siemens AG (speaker), NB Capital Research GmbH (speaker), NB Capital ApS (speaker), PharmaMar GmbH (speaker); (SC): Elekta, (speakers bureau), Brainlab (research); UN: (AstraZeneca, research) MN: (Brainlab (speaker, research), Astrazeneca (speaker)) BZ: (EBG MedAustron GmbH (Advisory Board), Elsevier (Advisory Board)); AR: Novocure (speaker), Merck (speaker). Ute Karin Dieckmann, Ahmed Gawish, Sabine Gerum, Eleni Gkika, Maximilian Grohmann, Juliane Hörner-Rieber, Simon Kirste, Rainer J. Klement, Christos Moustakis, Stephanie-Tanadini Lang, Peter Winkler, Andrea Wittig-Sauerwein, and Oliver Blanck declare that they have no competing interests.
